Board Changes

Genus PLC
17 January 2008


For immediate release                                         17 January 2008


                                    Genus plc                                            
                           ('Genus' or 'the Company')
                                        
                                        
                                 Board Changes


Genus, a world leading animal genetics company, announces that Nigel Turner will
be joining the Board as senior independent non-executive director with effect
from today.


Nigel (aged 58), was Chairman of Numis Securities Ltd and Deputy Chairman of
Numis Corporation plc from December 2005 to November 2007.

Previously he was Vice Chairman of ABN AMRO's Wholesale and Investment Bank in
which he had specific responsibility for the Global Corporate Finance and Equity
businesses. He joined the Dutch bank in 2000 from Lazard, where he was a partner
for 15 years and sat on its Supervisory Board.


Nigel will chair the Company's Remuneration Committee and be a member of the
Company's Audit and Nomination Committees.

Genus today also announces the retirement from the Board, with effect from today, 
of Edwin White. At the Company's Annual General Meeting held in November 2007, 
the Chairman announced that Edwin had indicated his intention to leave the Board, 
having been a Board member since the Company became publicly quoted seven years ago.

John Hawkins, Chairman of Genus, commented:

'We are delighted to welcome Nigel to the Board.  With Genus' recent move to the 
Official List, Nigel's considerable experience will greatly benefit Genus in its 
next stage of development as a listed company.'

 'I would also like to take this opportunity, on behalf of the Board, to thank 
Edwin for his valuable knowledge and contribution to the growth and success of 
Genus, and to wish him well in his retirement.'


There are no further details required to be disclosed under 9.6.13R of the
Listing Rules of the UK Listing Authority.


For further information please contact:

Genus plc                                          Tel: [phone]
John Hawkins, Chairman
Richard Wood, Chief Executive

Buchanan Communications                            Tel: [phone]
Charles Ryland / Suzanne Brocks

About Genus


Genus sells added value products for livestock farming and food producers by
creating advances to animal breeding through biotechnology. Its non-Genetically
Modified Organism (GMO) technology is applicable across all livestock species
but is only commercialised by Genus in the bovine and porcine farming sectors.


Genus' worldwide sales are made in seventy countries under the trade marks 'ABS'
(dairy and beef cattle) and 'PIC' (pigs) and comprise semen and breeding animals
with superior genetics to those animals currently in production. Customers use
Genus genetics in their herds to produce offspring with greater production
efficiency, milk and meat output and quality. These offspring are used to supply
the global dairy and meat supply chain.


Genus' competitive edge has been created from the ownership and control of
proprietary lines of breeding animals, the biotechnology used to improve them
and the Group's global production and distribution network.


Headquartered in Basingstoke, England, Genus companies operate in 30 countries
on six continents, with research laboratories located in Madison, USA.






                      This information is provided by RNS
            The company news service from the London Stock Exchange
             OBKDADD